-
CPL Completes Successful Virtual Health Canada Audit
contractpharma
June 04, 2021
The CDMO created a virtual tour of its facilities in response to the pandemic.
-
Argonaut Expands Lyophilization Facility
contractpharma
May 24, 2021
Argonaut Manufacturing Services, a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, is expanding its cGMP facilities in the Greater San Diego area of Carlsbad, CA.
-
Thermo Fisher, UCSF to Open Cell Therapy cGMP Mfg. Center
contractpharma
May 21, 2021
Thermo Fisher will build and operate a 44,000-sq.-ft. cell therapy development, manufacturing and collaboration center on UCSF's Mission Bay campus.
-
Cambrex Expands Analytical Services Capabilities
contractpharma
May 12, 2021
Cambrex has expanded its cGMP analytical testing capabilities at its site in Longmont, CO. Existing space at the site has been repurposed with cutting edge technologies and doubles the footprint of the laboratory operations.
-
Richter-Helm Triples cGMP Production Capacity
contractpharma
May 08, 2021
Richter-Helm BioLogics GmbH & Co. KG, a German CDMO, began construction for an expansion at its cGMP manufacturing facility in Bovenau, Germany.
-
Grand River Aseptic Manufacturing Earns Facility of the Year Award
contractpharma
April 30, 2021
Grand River Aseptic Manufacturing, a leading injectable contract development and manufacturing organization (CDMO), was awarded the 2021 Facility of the Year Award for Special Recognition of Operational Agility: COVID-19 by the International Society ...
-
Catalent Biologics Completes Madison Expansion
contractpharma
April 14, 2021
Catalent has completed the expansion of two new suites at its biologics drug substance development and manufacturing facility in Madison, WI, and began work on customer programs.
-
Anvisa says Covaxin producing facility does not meet CGMP standards
expresspharma
April 01, 2021
The Brazilian health regulator Anvisa has denied permission to import Bharat Biotech’s COVID-19 vaccine Covaxin into the country after its authorities found that the plant in which the vaccine is being made did not meet the Current Good Manufacturing ...
-
Altasciences Doubles Size of PA CDMO Facility
contractpharma
March 11, 2021
The additional 35,000-sq.-ft. building in Philadelphia will include warehouse and cGMP manufacturing suites.
-
Cascade Chemistry Initiates Expansion of cGMP Manufacturing Capacity
americanpharmaceuticalreview
February 23, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs (active pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures).